We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

26 hedge funds and large institutions have $9.19M invested in ImmuCell in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

186% more capital inflows, than outflows

Capital inflows: $951K | Capital outflows: $332K

1.06% more ownership

Funds ownership: 13.76% → 14.82% (+1.1%)

7% less funds holding

Funds holding: 28 → 26 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
9
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$485K
2
Morgan Stanley
Morgan Stanley
New York
+$163K
3
Renaissance Technologies
Renaissance Technologies
New York
+$152K
4
Citadel Advisors
Citadel Advisors
Florida
+$99.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.9K

Top Sellers

Rank Fund Capital Flow
1
DIG
Dauntless Investment Group
New Hampshire
-$213K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$64.7K
3
UBS Group
UBS Group
Switzerland
-$49.6K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$4.87K
5
JP Morgan Chase
JP Morgan Chase
New York
-$48

ICCC Hedge Fund Activity: Q2 2025 in Review

26 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2025, worth a combined $9.19M — up 55% from $5.92M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ICCC and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $485K. The largest seller was Dauntless Investment Group, cutting an estimated $213K.

  • 26 institutional investors held ImmuCell (ICCC) as of Q2 2025, down from 28 in Q1 2025.
  • Funds reported $9.19M of ImmuCell stock for Q2 2025, up 55% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q2 2025 and 3 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q2 2025 was Vanguard Group, an estimated $485K added.
  • The largest ImmuCell seller in Q2 2025 was Dauntless Investment Group, an estimated $213K sold.

Based on aggregated 13F filings for Q2 2025.